Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Synovial Fluids from Patients with Rheumatoid Arthritis or Osteoarthritis

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2000 Jun 2

PMID 10834863

Citations 188

Authors

Y Yoshihara

H Nakamura

K Obata

H Yamada

T Hayakawa

K Fujikawa

Y Okada

Affiliations

Soon will be listed here.

Abstract

Objective: Matrix metalloproteinases (MMPs) are expressed in joint tissues of patients with rheumatoid arthritis (RA) and osteoarthritis (OA). The objective of this study was to define the steady state levels of seven different MMPs and two tissue inhibitors of metalloproteinases (TIMPs) as well as the potential metalloproteinase activity in the synovial fluid (SF) to provide more insight into the role of MMPs in cartilage destruction in RA and OA.

Methods: Levels of MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-13, TIMP-1, and TIMP-2 in SF aspirated from knee joints of 97 patients with RA and 103 patients with OA were measured by the corresponding one step sandwich enzyme immunoassays. Proteolytic activity of MMPs in these SFs was examined in an assay using [(3)H]carboxymethylated transferrin substrate in the presence of inhibitors of serine and cysteine proteinases after activation with p-aminophenylmercuric acetate (APMA). Destruction of RA knee joints was radiographically evaluated.

Results: Levels of MMP-1, MMP-2, MMP-3, MMP-8, and MMP-9 were significantly higher in RA SF than in OA SF. MMP-7 and MMP-13 were detectable in more than 45% of RA SFs and in less than 20% of OA SFs, respectively. Among the MMPs examined, MMP-3 levels were extremely high compared with those of other MMPs. Direct correlations were seen between the levels of MMP-1 and MMP-3 and between those of MMP-8 and MMP-9 in RA SF. Although the levels of MMP-1 and MMP-3 increased even in the early stage of RA, those of MMP-8 and MMP-9 were low in the early stage and increased with the progression of RA. Molar ratios of the total amounts of the MMPs to those of the TIMPs were 5.2-fold higher in patients with RA than in OA, which was significant. APMA-activated metalloproteinase activity in SF showed a similar result, and a direct correlation was seen between the molar ratios and the activity in RA SF.

Conclusions: Our results show that high levels of MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, and TIMP-1 are present in RA SF and suggest that once these MMPs are fully activated, they have an imbalance against TIMPs, which may contribute to the cartilage destruction in RA.

Citing Articles

A versatile platform based on matrix metalloproteinase-sensitive peptides for novel diagnostic and therapeutic strategies in arthritis.

Li M, Deng T, Chen Q, Jiang S, Li H, Li J Bioact Mater. 2025; 47:100-120.

PMID: 39897588 PMC: 11787566. DOI: 10.1016/j.bioactmat.2025.01.011.

Propionibacterium freudenreichii MJ2-derived extracellular vesicles inhibit RANKL-induced osteoclastogenesis and improve collagen-induced rheumatoid arthritis.

Woo H, Cho J, Lim Y Sci Rep. 2024; 14(1):24973.

PMID: 39443658 PMC: 11500175. DOI: 10.1038/s41598-024-76911-y.

Pathophysiology and Evolving Treatment Options of Septic Arthritis: A Narrative Review.

Kaye A, Greene D, Alvarez-Amado A, Townsend H, Forte M, Vasterling M Cureus. 2024; 16(7):e65883.

PMID: 39219968 PMC: 11364462. DOI: 10.7759/cureus.65883.

Fibroblast-like synoviocytes orchestrate daily rhythmic inflammation in arthritis.

Downton P, Dickson S, Ray D, Bechtold D, Gibbs J Open Biol. 2024; 14(7):240089.

PMID: 38981514 PMC: 11285822. DOI: 10.1098/rsob.240089.

The Nrf2/HO-1 pathway participates in the antiapoptotic and anti-inflammatory effects of platelet-rich plasma in the treatment of osteoarthritis.

Du G, Sun X, He S, Mi L Immun Inflamm Dis. 2024; 12(6):e1169.

PMID: 38860757 PMC: 11165680. DOI: 10.1002/iid3.1169.

References

Larsen A, Dale K, Eek M . Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh). 1977; 18(4):481-91. DOI: 10.1177/028418517701800415. View

Farr M, Wainwright A, Salmon M, Hollywell C, Bacon P . Platelets in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int. 1984; 4(1):13-7. DOI: 10.1007/BF00683878. View

COOPER T, Eisen A, Stricklin G, Welgus H . Platelet-derived collagenase inhibitor: characterization and subcellular localization. Proc Natl Acad Sci U S A. 1985; 82(9):2779-83. PMC: 397649. DOI: 10.1073/pnas.82.9.2779. View

Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K . Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986; 29(8):1039-49. DOI: 10.1002/art.1780290816. View

Okada Y, Nagase H, Harris Jr E . A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J Biol Chem. 1986; 261(30):14245-55. View

Frisch S, Clark E, Werb Z . Coordinate regulation of stromelysin and collagenase genes determined with cDNA probes. Proc Natl Acad Sci U S A. 1987; 84(9):2600-4. PMC: 304705. DOI: 10.1073/pnas.84.9.2600. View

Stephenson M, Goldring M, Birkhead J, Krane S, Rahmsdorf H, Angel P . Stimulation of procollagenase synthesis parallels increases in cellular procollagenase mRNA in human articular chondrocytes exposed to recombinant interleukin 1 beta or phorbol ester. Biochem Biophys Res Commun. 1987; 144(2):583-90. DOI: 10.1016/s0006-291x(87)80006-2. View

Cawston T, McLaughlin P, Hazleman B . Paired serum and synovial fluid values of alpha 2-macroglobulin and TIMP in rheumatoid arthritis. Br J Rheumatol. 1987; 26(5):354-8. DOI: 10.1093/rheumatology/26.5.354. View

Arnett F, Edworthy S, Bloch D, McShane D, Fries J, Cooper N . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31(3):315-24. DOI: 10.1002/art.1780310302. View

10.

Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H . Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis. 1989; 48(8):645-53. PMC: 1003840. DOI: 10.1136/ard.48.8.645. View

11.

Chatham W, Heck L, Blackburn Jr W . Ligand-dependent release of active neutrophil collagenase. Arthritis Rheum. 1990; 33(2):228-34. DOI: 10.1002/art.1780330211. View

12.

Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T . Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma. J Immunol Methods. 1990; 127(1):103-8. DOI: 10.1016/0022-1759(90)90345-v. View

13.

Okada Y, Gonoji Y, Nakanishi I, Nagase H, Hayakawa T . Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium. Virchows Arch B Cell Pathol Incl Mol Pathol. 1990; 59(5):305-12. DOI: 10.1007/BF02899418. View

14.

Gravallese E, Darling J, Ladd A, Katz J, Glimcher L . In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum. 1991; 34(9):1076-84. DOI: 10.1002/art.1780340903. View

15.

McCachren S . Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum. 1991; 34(9):1085-93. DOI: 10.1002/art.1780340904. View

16.

Walakovits L, Moore V, Bhardwaj N, Gallick G, Lark M . Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum. 1992; 35(1):35-42. DOI: 10.1002/art.1780350106. View

17.

Nguyen Q, Mort J, Roughley P . Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage. J Clin Invest. 1992; 89(4):1189-97. PMC: 442978. DOI: 10.1172/JCI115702. View

18.

Okada Y, Shinmei M, Tanaka O, Naka K, Kimura A, Nakanishi I . Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest. 1992; 66(6):680-90. View

19.

Birkedal-Hansen H, Moore W, Bodden M, Windsor L, DeCarlo A, Engler J . Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993; 4(2):197-250. DOI: 10.1177/10454411930040020401. View

20.

Clark I, Powell L, Ramsey S, Hazleman B, Cawston T . The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 1993; 36(3):372-9. DOI: 10.1002/art.1780360313. View